supplements xp bpc 157 BPC-157 Benefits, Dosage & Before/After Results BPC 157 (Body Protection Compound-157)

How Is B12 Delivered Through an IV Infusion

Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence

[DOI] [PubMed] [Google Scholar] 190.Mota A, Sahebghadam Lotfi A, Barzin J, Hatam M, Adibi B, Khalaj Z, et al

489,490,491 Extensive preclinical data demonstrate that overactivity of mGluR5 is central to the pathogenesis of fragile X syndrome

That is what we know about it